Answer
Moclobemide (Manerix) reversibly inhibits monoamine oxidase, preferentially type A, reducing the breakdown of noradrenaline, dopamine and serotonin and increasing their extracellular concentrations in the brain.
Sources for this answer
- Manerix 300mgViatris (formerly Mylan or Upjohn) · emc · SmPC §5.1 Pharmacodynamic properties · Version 10Document updated
Sources checked